| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Legal Officer | SVP, GC &Secretary +1 more
3 companies
Keating Laurie is a Director at Immuneering Corp with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 17 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | IMRX Immuneering Corp | Director | Buy | 7,000 | $5.00 | $35,000.00 | +100.0% | +40.9% | +79.3% | |
| May 6, 2022 | PEPG Pepgen Inc. | Director | Buy | 4,166 | $12.00 | $49,992.00 | New | -6.7% | +15.8% | |
| Aug 5, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 10,000 | $188.95 | $1,889,500.00 | -66.1% | -10.8% | +12.7% | |
| Aug 3, 2021 | IMRX Immuneering Corp | Director | Buy | 7,000 | $15.00 | $105,000.00 | New | +40.0% | -64.3% | |
| Jul 12, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 6,812 | $178.96 | $1,219,098.00 | -30.9% | +15.5% | -17.6% | |
| Jun 9, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sell | 1,734 | $154.00 | $267,036.00 | -25.3% | +19.6% | -14.2% | |
| Jan 13, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 9,027 | $169.90 | $1,533,698.00 | -43.4% | - | - | |
| Jan 12, 2021 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 15,699 | $159.91 | $2,510,351.00 | -61.8% | - | - | |
| Jul 13, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 47,250 | $160.67 | $7,591,790.43 | -21.2% | - | - | |
| Apr 20, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Legal Officer | Sale+OE | 10,000 | $139.00 | $1,390,000.00 | -40.8% | - | - |